Clicky

ATAI Life Sciences N.V.(ATAI)

Description: atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, as well as the emergence of therapies that previously may have been overlooked or underused, including psychedelic compounds and digital therapeutics. atai is headquartered in Berlin, with offices in New York and London.


Keywords: Biopharmaceutical Medication Disability Mental Health Psychiatry Mental Disorder Positive Psychology Mental Health Disorders Social Constructionism

Home Page: www.atai.life

ATAI Technical Analysis

Krausenstrasse 9-10
Berlin, 10117
Germany
Phone: 49 89 2153 9035


Officers

Name Title
Mr. Christian Angermayer Founder & Chairman of the Supervisory Board
Mr. Florian Brand Co-founder & CEO
Dr. Srinivas G. Rao M.D., Ph.D. Co-Founder & Chief Scientific Officer
Dr. Rolando Gutierrez-Esteinou M.D. Chief Medical Officer
Mr. Gregory L. Weaver CPA, M.B.A. Non-Employee Advisor
Mr. Stephen B. Bardin MD & CFO
Mr. Frank Stegert VP of Investment & Venture Management
Ms. Anne Johnson Chief Accounting Officer
Ms. Madison Crawford Sr. Mang. of Accounting
Mr. Aaqil Anwar Mang. of Corp. Fin. & Investor Relations

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.7768
Price-to-Sales TTM: 1194.3
IPO Date: 2021-06-18
Fiscal Year End: December
Full Time Employees: 87
Back to stocks